| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 83.80B | 85.92B | 83.10B | 79.43B | 72.98B | 70.93B |
| Gross Profit | 24.13B | 24.90B | 23.73B | 19.79B | 12.97B | 17.39B |
| EBITDA | 12.29B | 12.17B | 12.16B | 9.37B | 4.30B | 8.99B |
| Net Income | 5.20B | 7.01B | 4.44B | 3.52B | -2.04B | 2.53B |
Balance Sheet | ||||||
| Total Assets | 109.49B | 113.73B | 107.62B | 103.50B | 104.90B | 104.93B |
| Cash, Cash Equivalents and Short-Term Investments | 24.03B | 24.72B | 23.34B | 14.92B | 16.03B | 12.48B |
| Total Debt | 31.99B | 30.21B | 33.07B | 32.28B | 39.70B | 36.91B |
| Total Liabilities | 51.80B | 48.80B | 50.81B | 48.68B | 53.94B | 50.42B |
| Stockholders Equity | 57.69B | 64.92B | 56.81B | 54.82B | 50.95B | 54.51B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.90B | 10.57B | 6.16B | 3.10B | -4.54B |
| Operating Cash Flow | 0.00 | 10.82B | 12.22B | 8.38B | 4.67B | 5.85B |
| Investing Cash Flow | 0.00 | -2.92B | -9.01B | 1.05B | -4.15B | -11.61B |
| Financing Cash Flow | 0.00 | -4.42B | -1.72B | -8.79B | 888.00M | 3.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥60.10B | 8.50 | ― | 2.44% | 3.38% | 57.67% | |
70 Outperform | ¥65.54B | 19.80 | ― | 3.98% | 0.60% | -6.50% | |
64 Neutral | ¥32.10B | 9.20 | ― | 0.72% | 6.21% | 167.11% | |
63 Neutral | ¥69.85B | 22.50 | ― | 0.34% | 10.22% | 13.91% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
56 Neutral | ¥196.68B | 9.92 | 7.56% | 2.84% | 2.53% | -4.69% | |
56 Neutral | ¥89.31B | 10.54 | ― | 3.59% | 6.25% | 246.08% |